The Clorox Company (NYSE:CLX) Shares Sold by W.H. Cornerstone Investments Inc.

W.H. Cornerstone Investments Inc. lowered its stake in The Clorox Company (NYSE:CLX) by 17.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,616 shares of the company’s stock after selling 561 shares during the quarter. W.H. Cornerstone Investments Inc.’s holdings in Clorox were worth $373,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. Fortitude Family Office LLC purchased a new stake in shares of Clorox during the fourth quarter worth about $29,000. Tyler Stone Wealth Management raised its holdings in shares of Clorox by 64.5% during the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the last quarter. Hartford Financial Management Inc. lifted its position in shares of Clorox by 57.1% in the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock valued at $37,000 after acquiring an additional 93 shares in the last quarter. Valley National Advisers Inc. boosted its stake in shares of Clorox by 458.3% in the fourth quarter. Valley National Advisers Inc. now owns 268 shares of the company’s stock worth $38,000 after acquiring an additional 220 shares during the last quarter. Finally, BKM Wealth Management LLC purchased a new stake in shares of Clorox during the fourth quarter worth approximately $41,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 1.0 %

CLX stock traded down $1.44 during mid-day trading on Friday, hitting $138.23. 2,036,238 shares of the company were exchanged, compared to its average volume of 1,340,454. The business has a fifty day simple moving average of $148.45 and a 200-day simple moving average of $143.43. The firm has a market capitalization of $17.17 billion, a P/E ratio of 71.62, a PEG ratio of 2.16 and a beta of 0.44. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $176.24. The company has a quick ratio of 0.57, a current ratio of 0.90 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter last year, the firm earned $1.51 EPS. The firm’s revenue for the quarter was down 5.3% on a year-over-year basis. On average, equities research analysts predict that The Clorox Company will post 5.83 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a yield of 3.47%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s payout ratio is 248.71%.

Analysts Set New Price Targets

CLX has been the topic of several recent research reports. Morgan Stanley reaffirmed an “equal weight” rating and set a $160.00 target price on shares of Clorox in a research note on Tuesday, March 26th. The Goldman Sachs Group initiated coverage on shares of Clorox in a research note on Friday, March 1st. They set a “sell” rating and a $140.00 price objective for the company. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a research note on Tuesday, March 26th. DA Davidson restated a “neutral” rating and issued a $162.00 price target on shares of Clorox in a research report on Wednesday, April 17th. Finally, Barclays reduced their price objective on Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a research report on Thursday. Four analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $146.43.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.